OpenAI Bought a Startup to Get New Medicines Out Faster
A new medicine takes 10 to 15 years to go from discovery to approval in the US. OpenAI bought Orchestra Bio to speed that up.
Orchestra says making a new drug takes thousands of decisions that depend on each other. Its AI agents keep track of them so scientists can fix problems before they cause delays.
OpenAI is adding Orchestra to Rosalind, its AI for biology research.
- OpenAI didn’t say how much it paid.
- Orchestra Bio is four years old.
- OpenAI already works with Ozempic maker Novo Nordisk and COVID vaccine maker Moderna.
- OpenAI announced the deal about two hours after Anthropic’s antivenom post.
Which lab do you think gets an AI-designed drug approved first?
